Skip to main content

Coccidioidomycosis, Pediatric

Camille Sabella, MD Reviewed 10/2018
 


BASICS

DESCRIPTION

Coccidioidomycosis is an endemic systemic mycosis resulting in both asymptomatic and life-threatening disseminated infections. 

EPIDEMIOLOGY

  • Coccidioides spp. are dimorphic fungi that ...

DIAGNOSIS

HISTORY

  • Travel or residence in an endemic area is typical. Risk factors for disseminated infection should be sought.

  • Acute pneumonia

    • Fever, dry or productive cough, and pleuritic chest pain; he...

TREATMENT

MEDICATION

  • Uncomplicated or minor disease is self-limited and usually resolves without specific antifungal therapy.

    • Controversial whether treatment reduces illness severity or risk of severe c...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

Patient Monitoring

  • Patients with mild primary respiratory tract infections who are not treated with antifungal therapy should be assessed at 3 to 6 months interval...

ADDITIONAL READING

  • Ampel NM. New perspectives on coccidioidomycosis. Proc Am Thorac Soc.  2010;7(3):181–185. [View Abstract on OvidInsights]

  • Centers for Disease Control and Prevention. Increase in...

CODES

ICD9

  • 114.9 Coccidioidomycosis, unspecified

  • 114.5 Pulmonary coccidioidomycosis, unspecified

  • 114.1 Primary extrapulmonary coccidioidomycosis

  • 114.0 Primary coccidioidomycosis (pulmonary)

  • 114.9 Coccidioi...

FAQ

  • Q: Do all patients with symptomatic primary respiratory infection due to C. immitis require treatment?

  • A: No. Because >95% of initial pulmonary infections are self-limited, treatment is not alwa...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×